"Like, when I worked with men, I had a really hard time disappointing them or saying something that wasn't aligned with their ...

Before I went through personal development, I was closed-minded. Negative. Jealous. Thought I knew better. I thought that successful people were just lucky. That I was born less privileged than the ...

Why we procrastinate has less to do with willpower than with how flexibly our brains handle stress and discomfort - and the ...

There’s something missing from the conversation about lifelong learning. Many of us already know we’ll need to absorb new knowledge and pick up new skills in order to stay competitive in the future ...

When the wheels started falling off the ‘business as usual’ bandwagon in March, I was apprehensive about what lay ahead. Talk of taking our entire lives online triggered internal resistance. I’m a ...

Unlearn seems to have retained a lesson or two about fundraising: The digital twin developer announced this week that it has raised another $50 million, echoing its last funding round two years ago.

Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...

Throughout the history of medicine, drug developers have tried to make clinical trials faster and more efficient. Artificial intelligence and machine-learning methods are some of the newer approaches ...

While a lot of learning happens at Calvin University in any given week, the week of October 30—November 6, 2023, takes a different twist. Jane Bruin, director of the center for intercultural student ...

As leaders struggle to navigate today’s complex and rapidly changing world, many of them are finding that the tactics and behaviors that served them well in the past are less effective when dealing ...

Millions of adults are coping with chronic back pain, which can significantly limit their ability to work and do other daily activities. But researchers in Colorado are studying a unique non-drug ...

Unlearn and Merck KGaA have announced a partnership to accelerate drug trials using medical digital twins of patients. Unlearn uses recent developments from deep learning to create digital twins of ...